<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Sargramostim (GM-CSF)</title><link>http://www.unboundmedicine.com/medline/ebm/research/Sargramostim_(GM-CSF)</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18838710/full_citation/Immunoembolization_of_Malignant_Liver_Tumors_Including_Uveal_Melanoma_Using_Granulocyte_Macrophage_Colony_Stimulating_Factor_</link><description>Sato T, Eschelman DJ, Gonsalves CF, et al. <br/><span class="title">Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2008 Oct 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18838710/abstract/Immunoembolization_of_Malignant_Liver_Tumors_Including_Uveal_Melanoma_Using_Granulocyte_Macrophage_Colony_Stimulating_Factor_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18838710/full_citation/Immunoembolization_of_Malignant_Liver_Tumors_Including_Uveal_Melanoma_Using_Granulocyte_Macrophage_Colony_Stimulating_Factor_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=18838710">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18838710/Immunoembolization_of_Malignant_Liver_Tumors_Including_Uveal_Melanoma_Using_Granulocyte_Macrophage_Colony_Stimulating_Factor_">Find Related Articles</a> </description></item><item><title>Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18785912/full_citation/Sequential_administration_of_sargramostim_and_filgrastim_in_pediatric_allogeneic_stem_cell_transplantation_recipients_undergoing_myeloablative_conditioning_</link><description>Waxman IM, Militano O, Baldinger L, et al. <br/><span class="title">Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pediatric transplantation">Pediatr Transplant 2008 Sep 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18785912/abstract/Sequential_administration_of_sargramostim_and_filgrastim_in_pediatric_allogeneic_stem_cell_transplantation_recipients_undergoing_myeloablative_conditioning_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18785912/full_citation/Sequential_administration_of_sargramostim_and_filgrastim_in_pediatric_allogeneic_stem_cell_transplantation_recipients_undergoing_myeloablative_conditioning_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18785912/Sequential_administration_of_sargramostim_and_filgrastim_in_pediatric_allogeneic_stem_cell_transplantation_recipients_undergoing_myeloablative_conditioning_">Find Related Articles</a> </description></item><item><title>[Pulmonary alveolar proteinosis: a disease caused by surfactant accumulation, and new treatment with sargramostim]</title><link>http://www.unboundmedicine.com/medline/ebm/record/18666660/full_citation/[Pulmonary_alveolar_proteinosis:_a_disease_caused_by_surfactant_accumulation_and_new_treatment_with_sargramostim]</link><description>Huisman P, Grutters JC, van den Bosch JM <br/><span class="title">[Pulmonary alveolar proteinosis: a disease caused by surfactant accumulation, and new treatment with sargramostim] [English Abstract, Journal Article]</span><br/><span class="source" title="Nederlands tijdschrift voor geneeskunde">Ned Tijdschr Geneeskd 2008 Jun 28; 152(26):1450-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18666660/abstract/[Pulmonary_alveolar_proteinosis:_a_disease_caused_by_surfactant_accumulation_and_new_treatment_with_sargramostim]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18666660/full_citation/[Pulmonary_alveolar_proteinosis:_a_disease_caused_by_surfactant_accumulation_and_new_treatment_with_sargramostim]">Full Citation</a></description></item><item><title>Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18593361/full_citation/Sequential_administration_of_GM_CSF__Sargramostim__and_IL_2_+/__autologous_vaccine_as_adjuvant_therapy_in_cutaneous_melanoma:_an_interim_report_of_a_phase_II_clinical_trial_</link><description>Elias EG, Zapas JL, McCarron EC, et al. <br/><span class="title">Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Cancer biotherapy &amp; radiopharmaceuticals">Cancer Biother Radiopharm 2008 Jun; 23(3):285-91.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18593361/abstract/Sequential_administration_of_GM_CSF__Sargramostim__and_IL_2_+/__autologous_vaccine_as_adjuvant_therapy_in_cutaneous_melanoma:_an_interim_report_of_a_phase_II_clinical_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18593361/full_citation/Sequential_administration_of_GM_CSF__Sargramostim__and_IL_2_+/__autologous_vaccine_as_adjuvant_therapy_in_cutaneous_melanoma:_an_interim_report_of_a_phase_II_clinical_trial_">Full Citation</a></description></item><item><title>Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18483371/full_citation/Clinical_and_biological_effects_of_neoadjuvant_sargramostim_and_thalidomide_in_patients_with_locally_advanced_prostate_carcinoma_</link><description>Garcia JA, Klein EA, Magi-Galluzzi C, et al. <br/><span class="title">Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma. [Journal Article]</span><br/><span class="source" title="Clinical cancer research : an official journal of the American Association for Cancer Research">Clin Cancer Res 2008 May 15; 14(10):3052-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18483371/abstract/Clinical_and_biological_effects_of_neoadjuvant_sargramostim_and_thalidomide_in_patients_with_locally_advanced_prostate_carcinoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18483371/full_citation/Clinical_and_biological_effects_of_neoadjuvant_sargramostim_and_thalidomide_in_patients_with_locally_advanced_prostate_carcinoma_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18483371/Clinical_and_biological_effects_of_neoadjuvant_sargramostim_and_thalidomide_in_patients_with_locally_advanced_prostate_carcinoma_">Find Related Articles</a> </description></item><item><title>[Accelerated postoperative immunotherapy for cerebral glioma]</title><link>http://www.unboundmedicine.com/medline/ebm/record/18416069/full_citation/[Accelerated_postoperative_immunotherapy_for_cerebral_glioma]</link><description><span class="title">[Accelerated postoperative immunotherapy for cerebral glioma] [English Abstract, Journal Article]</span><br/><span class="source" title="Voprosy onkologii">Vopr Onkol 2008; 54(1):102-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18416069/abstract/[Accelerated_postoperative_immunotherapy_for_cerebral_glioma]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18416069/full_citation/[Accelerated_postoperative_immunotherapy_for_cerebral_glioma]">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18416069/[Accelerated_postoperative_immunotherapy_for_cerebral_glioma]">Find Related Articles</a> </description></item><item><title>The role of sargramostim (rhGM-CSF) as immunotherapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18039636/full_citation/The_role_of_sargramostim__rhGM_CSF__as_immunotherapy_</link><description>Waller EK <br/><span class="title">The role of sargramostim (rhGM-CSF) as immunotherapy. [Journal Article]</span><br/><span class="source" title="The oncologist">Oncologist 2007.:22-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18039636/abstract/The_role_of_sargramostim__rhGM_CSF__as_immunotherapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18039636/full_citation/The_role_of_sargramostim__rhGM_CSF__as_immunotherapy_">Full Citation</a> | <a href="http://theoncologist.alphamedpress.org/cgi/pmidlookup%3fview=long%26amp;pmid=18039636">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18039636/The_role_of_sargramostim__rhGM_CSF__as_immunotherapy_">Find Related Articles</a> </description></item><item><title>Difficulties with fungal infections in acute myelogenous leukemia patients: immune enhancement strategies.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18039633/full_citation/Difficulties_with_fungal_infections_in_acute_myelogenous_leukemia_patients:_immune_enhancement_strategies_</link><description>Safdar A <br/><span class="title">Difficulties with fungal infections in acute myelogenous leukemia patients: immune enhancement strategies. [Journal Article]</span><br/><span class="source" title="The oncologist">Oncologist 2007.:2-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18039633/abstract/Difficulties_with_fungal_infections_in_acute_myelogenous_leukemia_patients:_immune_enhancement_strategies_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18039633/full_citation/Difficulties_with_fungal_infections_in_acute_myelogenous_leukemia_patients:_immune_enhancement_strategies_">Full Citation</a> | <a href="http://theoncologist.alphamedpress.org/cgi/pmidlookup%3fview=long%26amp;pmid=18039633">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18039633/Difficulties_with_fungal_infections_in_acute_myelogenous_leukemia_patients:_immune_enhancement_strategies_">Find Related Articles</a> </description></item><item><title>Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17932977/full_citation/Granulocyte_macrophage_colony_stimulating_factor_ameliorates_DSS_induced_experimental_colitis_</link><description>Sainathan SK, Hanna EM, Gong Q, et al. <br/><span class="title">Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Inflamm Bowel Dis 2007 Oct 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17932977/abstract/Granulocyte_macrophage_colony_stimulating_factor_ameliorates_DSS_induced_experimental_colitis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17932977/full_citation/Granulocyte_macrophage_colony_stimulating_factor_ameliorates_DSS_induced_experimental_colitis_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/ibd.20279">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17932977/Granulocyte_macrophage_colony_stimulating_factor_ameliorates_DSS_induced_experimental_colitis_">Find Related Articles</a> </description></item><item><title>Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17660841/full_citation/Reduced_intensity_allogeneic_umbilical_cord_blood_transplantation_in_children_and_adolescent_recipients_with_malignant_and_non_malignant_diseases_</link><description>Bradley MB, Satwani P, Baldinger L, et al. <br/><span class="title">Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Bone Marrow Transplant 2007 Jul 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17660841/abstract/Reduced_intensity_allogeneic_umbilical_cord_blood_transplantation_in_children_and_adolescent_recipients_with_malignant_and_non_malignant_diseases_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17660841/full_citation/Reduced_intensity_allogeneic_umbilical_cord_blood_transplantation_in_children_and_adolescent_recipients_with_malignant_and_non_malignant_diseases_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17660841/Reduced_intensity_allogeneic_umbilical_cord_blood_transplantation_in_children_and_adolescent_recipients_with_malignant_and_non_malignant_diseases_">Find Related Articles</a> </description></item></channel></rss>